Archive for the ‘Uncategorized’ Category

Insights From the Geographic Spread of the Lyme Disease Epidemic

https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciy510/5039131?redirectedFrom=fulltext

Insights from the Geographic Spread of the Lyme Disease Epidemic

Taylor Eddens, Ph.D Daniel J Kaplan, M.D Alyce J M Anderson, Ph.D Andrew J Nowalk, M.D.,Ph.D Brian T Campfield, M.D
Clinical Infectious Diseases, ciy510, https://doi.org/10.1093/cid/ciy510
Published: 16 June 2018

Reproduced by permission of Oxford University Press on behalf of the Infectious Diseases Society of America. 9c) The Author(s) 2018. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. Please visit: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciy510/5039131

Abstract
Background
Lyme disease is the most common reportable zoonotic infection in the United States. Recent data suggests spread of the Ixodes tick vector and increasing incidence of Lyme disease in several states, including Pennsylvania. We sought to determine the clinical presentation and healthcare utilization patterns for pediatric Lyme disease in western Pennsylvania.

Methods
The electronic medical records of all patients with an ICD9 diagnosis of Lyme disease between 2003-2013 at Children’s Hospital of Pittsburgh were individually reviewed for cases meeting the 2011 CDC case definition for Lyme disease. 773 patients meeting these criteria were retrospectively analyzed for patient demographics, disease manifestations, and healthcare utilization.

Results
An exponential increase in Lyme disease occurred in the pediatric population of western Pennsylvania. There was a southwestward migration of Lyme cases, with a shift in concentration from rural to non-rural zip codes. Healthcare provider involvement also changed from subspecialists to primary care pediatricians(PCP) and emergency departments(ED). Patients from non-rural zip codes more commonly presented to the ED, while patients from rural zip codes utilized PCPs and EDs similarly.

Conclusions
The current study details the conversion of western Pennsylvania from a Lyme-naïve to a Lyme-epidemic area, highlighting changes in clinical presentation and healthcare utilization as the epidemic evolved. Presenting symptoms and provider-type differed between those from rural and non-rural zip codes. By understanding the temporospatial epidemiology, disease presentation and healthcare utilization of Lyme, the current study may inform future public health initiatives regionally while serving as an archetype for other areas at-risk for Lyme epidemics.

 

 

 

Splenic Rupture From Babesiosis, An Emerging Concern? A Systematic Review of Current Literature

https://www.sciencedirect.com/science/article/pii/S1877959X17303333?via%3Dihub

Splenic rupture from babesiosis, an emerging concern? A systematic review of current literature

Shuo Li, Bobby Goyal, Joseph D.Cooper, Ahmed Abdelbaki, Nishant Gupta, Yogesh Kumara

Abstract
Babesiosis is a relatively common tick-borne parasitic infection of erythrocytes primarily affecting the northeastern United States. Babesiosis’ prevalence and presentation have earned it the monikers “malaria of the northeast” and “Nantucket fever”. Clinical presentation ranges from asymptomatic infection to severe infection including acute respiratory distress syndrome (ARDS) and disseminated intravascular coagulopathy (DIC) or death. Since 2008, there have been a number of reports of splenic rupture in patients with the disease. We seek to provide a further understanding of this process, with the report of a case of splenic rupture followed by a systematic review of the current literature. We found that 87% of splenic rupture secondary to babesiosis occurred in male patients who are otherwise healthy, with an average of 56 years. Computed tomography is a reliable mode of diagnosis, and hemoperitoneum is the most common imaging finding. Patients with splenic rupture due to human babesiosis were successfully treated by various management strategies, such as conservative non-operative approach, splenic artery embolization, and splenectomy. The modality of treatment depends on patient’s clinical course and hemodynamic stability, although spleen conserving strategy should be considered first whenever possible.

______________

For more:  https://madisonarealymesupportgroup.com/2016/01/16/babesia-treatment/

https://madisonarealymesupportgroup.com/2018/01/24/phase-ii-malaria-meds-100-cured-good-for-babesia/

https://madisonarealymesupportgroup.com/2016/12/05/babesia-cure-update/

https://madisonarealymesupportgroup.com/2018/06/08/two-cases-of-babesia/

https://madisonarealymesupportgroup.com/2018/02/20/babesia-and-heart-issues/

https://madisonarealymesupportgroup.com/2018/05/31/widespread-babesiosis-in-canada/

https://madisonarealymesupportgroup.com/2018/03/07/babesia-tests-approved-by-fda-for-screening-purposes/

https://madisonarealymesupportgroup.com/2017/08/08/transfusion-transmitted-babesiosis-in-nonendemic-areas/

July 24, 2018 Next Tick-borne Disease Working Group Meeting

https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2018-07-24/index.html

The seventh meeting of the Tick-borne Disease Working Group will be held on July 24, 2018, from 10:00 a.m. to 4:00 p.m. EDT. The Working Group will review and vote on the content of the five chapters that will be submitted into the Working Group Congressional Report.

Please Note: If you would like to receive a copy of the draft chapters, please submit a request to tickbornedisease@hhs.gov. The meeting materials will be emailed to you prior to the meeting.

Members of the public can attend the live meeting via webcast.
Instructions for attending this virtual meeting will be posted prior to the meeting.

Public Comment – Information and Instructions

The Working Group invites public comment on issues related to its charge. You have the option of verbal comment, written comment or both. Thus, if you provide verbal comment, you may also submit it as written comment or submit written comment on a different issue.

Verbal (by phone) comments:
  • Requests to provide verbal public comment must be submitted via email by July 19, 2018 EDT to tickbornedisease@hhs.gov.
    In the Subject line please enter: Verbal Public Comment – July 24 Meeting.
  • A total of 30 minutes has been set aside for verbal comments. Each person will be limited to 3 minutes in order to accommodate as many speakers as possible.
  • If more requests are received than can be accommodated, speakers will be randomly selected.
  • Your remarks will be broadcast over a live webcast and will become part of the archived recording and meeting transcripts that will be posted on this website.
Written comments:
  • Written public comments must be submitted via email by July 19, 2018 EDT to tickbornedisease@hhs.gov.
    In the Subject line please enter: Written Public Comment – July 24 Meeting.
  • Written comments will be posted on the Tick-Borne Disease Working Group website and accessible to the public.
    IMPORTANT: When you submit your written comment, please include how you would like to be identified with your comment. That is, you may use your name or request to be anonymous. You may also include your city and/or state. If you are providing comments on behalf of an organization you also may include your name, organization, and organization email address. We do NOT post phone numbers or personal email addresses.
  • Comments should be no more than 4 pages in Calibri or Times New Roman, 11 point font. Text that exceeds the 4 pages will be deleted.
  • Written comments should either be provided in the body of the email, or in an attachment in Word format.
  • Please do not include graphics, images, or text boxes. If included, we will not be able to retain them. Simple tables are acceptable.
  • We can only retain links to “.gov” sites (state or federal). For all other reference sites, please insert the full URL (e.g., https://www.jscimedcentral.com/ClinicalCytology/clinicalcytology-3-1085.pdf).
  • Do not include attachments as supporting documentation to your written comments; instead, please list them as references.

Summer Campers Face Deadly Ticks & Mosquitoes

https://www.cnn.com/2018/06/24/health/bug-disease-preparedness/index.html

Summer campers face deadly ticks and mosquitoes

By Elizabeth Cohen and John Bonifield, CNN
June 25, 2018

US ‘not ready’ for potentially deadly bug diseases

In many parts of the United States, this weekend marks the start of summer sleepaway camp season, which means swimming, arts and crafts, marshmallow roasts — and, very often, ticks.

Of the more than 1,600 overnight camps that are members of the American Camp Association, more than a third are in New England and the mid-Atlantic states, where Lyme disease is particularly prevalent, according to the Centers for Disease Control and Prevention.

According to a May CDC report, cases of vector-borne diseases — those caused by viruses and bacteria carried by ticks, mosquitoes and other bugs — tripled in the United States from 2004 to 2016.

For years, experts have voiced concern that many local public health agencies are unprepared to control such pests and limit the spread of these diseases which include Lyme disease, dengue fever and Zika.

“I started to look into it, and the numbers were on the increase and didn’t show any signs of stopping,” said Lauren Rutkowski, who with her husband, Joel, owns Indian Head Camp for children in Equinunk, Pennsylvania. “As a mom and a camp director, I was concerned.”

Every summer from 2010 to 2014, seven or eight campers had confirmed or suspected tick bites at Indian Head, and each summer, three or four of those children tested positive for Lyme disease, according to Rutkowski. Lyme disease is a bacterial infection transmitted through bites from infected ticks, and if left untreated, it can spread to joints, the heart and the nervous system.

She said it’s not known whether the children contracted the disease from the tick bite they got at camp or from a previous tick bite at home.

In 2014, her son, Oakley, was bitten by a tick at the family’s camp, which hosts 650 children every summer. He did not contract Lyme disease.

The next year, Rutkowski hired a new service that helps fight ticks, including spraying the perimeter of the camp with pesticides and offering advice on how to get rid of habitats where ticks breed.

Since then, not a single camper is known to have been bitten by a tick, Rutkowski said.

Now, 123 camps use the service, Ivy Oaks Analytics, according to Isaiah Ham, who started the company after one of his summer campers contracted Lyme disease from a tick bite.

Ham, then a college student working as a counselor, said he wasn’t pleased with the camp’s response.

“The camp just kind of shrugged and thought it was just inevitable, like a hurricane; it was just part of being in the outdoors,” Ham remembered.

It’s unknown how many children are bitten by ticks at summer camps or how many camps are using services to mitigate the pests, according to Sam Borek, president of the New York/New Jersey section of the American Camp Association.

Camps don’t exist in a vacuum, of course, and there are concerns that state public health departments aren’t doing enough to fight diseases caused by ticks, mosquitoes and other pests.

“Mosquitoes, ticks, fleas can all carry very serious diseases that are life-threatening,” said Dr. Irwin Redlener, a professor at the Columbia University Mailman School of Public Health.

A report from the National Association of County and City Health Officials says 84% of programs to control diseases from mosquitoes need improvement. In 18 states, every program is falling short.

These programs often aren’t well-funded and aren’t equipped to do proper surveillance or prevention, Redlener said.

“We’re, simply put, not ready, and we should be,” he said.

Redlener and other experts have criticized President Trump for ignoring climate change, part of the reason for the proliferation of pests that carry diseases. (Please see my comment at end of article)

“We have to wonder why the president and the administration [are] not taking this issue more seriously,” he said.

The White House declined to comment on climate change, referring questions to the CDC, which makes clear on its website that climate change increases the number and geographic range of disease-carrying insects and ticks.

The White House statement also said the President takes such diseases seriously, requesting more than $49 million to fight them next year, an increase of $11 million over this year.

Back at Indian Head Camp, as the campers arrive on Saturday, they’re hoping for another summer without a tick bite.

“We’re ready,” Rutkowski said. “We just can’t wait to get them here.”

______________

**Comment**

There are many things to complain about; however, “climate change” in regards to ticks and proliferation of disease isn’t one of them:  https://madisonarealymesupportgroup.com/2017/08/14/canadian-tick-expert-climate-change-is-not-behind-lyme-disease/

How about we start doing good, unbiased science and get some answers?  

And there are far more guilty people (CDC, IDSA, and patent holders sitting on boards making decisions for patients) behind the denial of this plague and far more responsible for it than the president:

https://madisonarealymesupportgroup.com/2017/11/15/lyme-patients-file-lawsuit-against-idsa-and-insurers-over-treatment-denials/

https://madisonarealymesupportgroup.com/2018/06/14/corruption-human-rights-violations-against-lyme-doctors-scientists-and-parents-now-on-united-nations-record/

https://madisonarealymesupportgroup.com/2017/10/13/1st-officially-recognized-report-on-violations-of-lyme-patients-human-rights-is-released-updating-borreliosis-diagnostic-codes/

https://madisonarealymesupportgroup.com/2018/05/15/news-release-on-57-1-million-lyme-disease-lawsuit-filed-against-cdc/

The Corruption of Evidence Based Medicine – Killing For Profit

http://www.greenmedinfo.com/blog/corruption-evidence-based-medicine-killing-profit

The Corruption of Evidence Based Medicine — Killing for Profit

Tuesday, June 19th 2018
Written By: Dr. Jason Fung
This article is copyrighted by GreenMedInfo LLC, 2018

The idea of Evidence Based Medicine (EBM) is great. The reality, though, not so much. Human perception is often flawed, so the premise of EBM is to formally study medical treatments and there have certainly been some successes.

Consider the procedure of angioplasty. Doctors insert a catheter into the blood vessels of the heart and use a balloon like device to open up the artery and restore blood flow. In acute heart attacks studies confirm that this is an effective procedure. In chronic heart disease the COURAGE study and more recently the ORBITA study showed that angioplasty is largely useless. EBM helped distinguish the best use of an invasive procedure.

So, why do prominent physicians call EBM mostly useless? The 2 most prestigious journals of medicine in the world are The Lancet and The New England Journal of Medicine. Richard Horton, editor in chief of The Lancet said this in 2015 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960696-1/fulltext

The case against science is straightforward: much of the scientific literature, perhaps half, may simply be untrue

Dr. Marcia Angell, former editor in chief of NEJM wrote in 2009 that http://www.nybooks.com/articles/2009/01/15/drug-companies-doctorsa-story-of-corruption/

It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor

This has huge implications. Evidence based medicine is completely worthless if the evidence base is false or corrupted. It’s like building a wooden house knowing the wood is termite infested. What caused this sorry state of affairs? Well, Dr. Relman another former editor in chief of the NEJM said this in 2002  https://www.ncbi.nlm.nih.gov/pubmed/12561803

The medical profession is being bought by the pharmaceutical industry, not only in terms of the practice of medicine, but also in terms of teaching and research. The academic institutions of this country are allowing themselves to be the paid agents of the pharmaceutical industry. I think it’s disgraceful

The people in charge of the system — the editors of the most important medical journals in the world, gradually learn over a few decades that their life’s work is being slowly and steadily corrupted. Physicians and universities have allowed themselves to be bribed.

The examples in medicine are everywhere. Research is almost always paid for by pharmaceutical companies. But studies done by industry are well known to have positive results far more frequently https://www.ncbi.nlm.nih.gov/pubmed/20679560.  Trials run by industry are 70% more likely than government funded trials to show a positive result. Think about that for a second. If EBM says that 2+2 = 5 is correct 70% of the time, would you trust this sort of ‘science’?

Selective Publication — Negative trials (those that show no benefit for the drugs) are likely to be suppressed. For example, in the case of antidepressants, 36/37 https://www.nejm.org/doi/full/10.1056/NEJMsa065779 studies that were favourable to drugs were published. But of the studies not favorable to drugs, a paltry 3/36 were published. Selective publication of positive (for the drug company) results means that a review of the literature would suggest that 94% of studies favor drugs where in truth, only 51% were actually positive. Suppose you know that your stockbroker publishes all his winning trades, but suppresses all his losing trades. Would you trust him with your money? But yet, we trust EBM with our lives, even though the same thing is happening.

KillingForProfitGraph

Let’s look at the following graph of the number of trials completed versus those that were published. In 2008, the company Sanofi completed 92 studies but only a piddly 14 were published. Who gets to decide which gets published and which does not? Right. Sanofi. Which ones do you think will be published? The ones that favor its drugs, or the ones that prove their drugs do not work? Right. Keep in mind that this is the only rational course of action for Sanofi, or any other company to pursue. It’s idiotic to publish data that harms yourself. It’s financial suicide. So this sort of rational behavior will happen now, and it will not stop in the future. But knowing this, why do we still believe the evidence based medicine, when the evidence base is completely biased? An outside observer, only looking at all published data, will conclude that the drugs are far, far more effective than they are in reality. Yet, if you point this out in academic circles, people label you a quack, who does not ‘believe the evidence’.

KillingForProfitGraph2Rigging of Outcomes — Or consider the example of registration of primary outcomes. Prior to year 2000, companies doing trials did not need to declare what end points they measured. So they measure many different endpoints and simply figured out which one looked best and then declared the trial a success. Kind of like tossing a coin, looking at which one come up more, and saying that they were backing the winning side. If you measured enough outcomes, something was bound to come up positive.

In 2000, the government moved to stop these shenanigans. They required companies to register what they were measuring ahead of time. Prior to 2000, 57% of trials showed a positive result. After 2000, a paltry 8% showed good results. More evidence of the evidence base being completely corrupted by commercial interest, and the academic physicians who were getting rich on it tacitly allowing corruption because they know that you don’t bite the hand that feeds you

KillingForProfitExcerpt

‘Advertorials’ — Or this example of a review paper in the NEJM https://www.nejm.org/doi/pdf/10.1056/NEJMoa1001086 that fracture rates caused by the lucrative bisphosphonate drugs were “very rare”. Not only did the drug companies pay lots of consulting fees to the doctors, three of the authors of this review were full time employees! To allow an advertorial to be published as the best scientific fact is scandalous. Doctors, trusting the NEJM to publish quality, unbiased advice have no idea that this review article is pure advertising. Yet, we still consider the NEJM to be the very pinnacle of evidence based medicine. Instead, as all the editors of the journals sadly recognize, it has become lucre-based publishing. Mo money = better results.

Money from Reprints — The reasons for this problem is obvious to all  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964337/ — it’s insanely profitable for journals to take money from Big Pharma. Journals want to be read. So they all try to get a high Impact Factor (IF). To do this, you need to get cited by other authors. And nothing boosts ratings like a blockbuster produced by Big Pharma. They have the contacts and the sales force to make any study a landmark. A less obvious benefit is the fees that are generated by Big Pharma purchasing articles for reprint. If a company publishes an article in the NEJM, they may order several hundred thousand copies of the article to be distributed to unsuspecting doctors everywhere. These fees are not trivial. The NEJM publisher Massachusetts Medical Society gets 23% of its income from reprints. The Lancet — 41%. The American Medical Association — a gut busting 53%. No wonder these journals are ready to sell their readers (ordinary physicians) down the river. It pays. Who needs journalistic ethics when there’s a Mercedes in the driveway? Mo money, baby. Mo money.

Bribery of Journal Editors — A recent study by Liu et al in the BMJ https://www.bmj.com/content/359/bmj.j4619 shed more light on the problem of crooked journals. Crooked journal editors. Editors play a crucial role in determining the scientific dialogue by deciding which manuscripts are published. They determine who the peer reviewers are. Using the Open Payments database, they looked at how much money the editors of the most influential journals in the world were taking from industry sources. This includes ‘research’ payments, which are largely unregulated. As mention previously, much ‘research’ consists of going to meetings in exotic locale. It funny how many conferences are held in beautiful European cities like Barcelona, and how few are done in brutally cold Quebec City.

Of all journal editors that could be assessed, 50.6% were on the take. The average payment in 2014 was $27,564. Each. This does not include an average $37, 330 given for ‘research’ payments. Other particularly corrupt journals include:

KillingForProfitPayToEditors

This is slightly horrifying. Each editor of the Journal of the American College of Cardiology received, on average $475 072 personally and another $119 407 for ‘research’. With 35 editors, that’s about $15 million in bribes to doctors. No wonder the JACC loves drugs and devices. It pays the private school bills. Mo money = we’ll publish your crooked studies for you. Mo money, baby, mo money.

Publication Bias — The evidence base that EBM depends upon is completely biased. Some people think I’m really anti-Pharma, but this is not really true. Big Pharma companies have a duty to their shareholders to make money. They have no duty to patients. On the other hand, doctors have a duty to patients. Universities have a duty to remain unbiased.

It is the failure of doctors and universities to keep their greedy paws out of the corrupting influence of Big Pharma money that is the problem. If Big Pharma is allowed to spend lots of $$$ paying off doctors and universities and professors, then it should do so to maximize profits. That is their mission statement. Doctors love to blame Big Pharma companies because it takes peoples gaze off the real problem — lots of doctors taking $$$ from anybody who will pay. The pharma industry is not the problem. Bribery of university doctors is the problem — one that is easily fixed if the political will exists.

Consider this study:  https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.13336  Looking at studies in the field of neurodegenerative disease, researchers looked at all the studies that were started but never finished or never published. Approximately 28% of studies never made it to the finish line. That’s a problem. If all the studies that don’t look promising for drug candidates are not published, then it appears that the drugs are way way more effective than they really are. But the published ‘evidence base’ would falsely support the drug. Indeed, Pharma sponsored trials were 5 times more likely to be unpublished.

Imagine you have a coin flipping contest. Suppose a player call ‘Big Pharma” chooses heads, and also pays the coin flipper. Every time the coin flipper pulls up tails, the results don’t count. Every time it comes up heads, it counts. This happens 28% of the time. Now, instead of a 50/50 split of heads and tails, it’s more like a 66/34 split of heads/tails. So the ‘evidence based medicine’ lover claims that heads is far more likely to come up than tails, and castigates people who don’t believe the results as ‘anti-science’.

Evidence based medicine depends entirely upon having a reliable base of evidence (studies). If the evidence base is tampered with, and paid for, then EBM as a science is completely useless. Indeed, the very editors whose entire careers have been EBM have now discovered it to be worthless. Does the CEO of Phillip Morris (maker of Marlboro cigarettes http://www.greenmedinfo.com/disease/tobacco-toxicity) smoke? That tells you all you need to know about the health risks. Do the editors of the NEJM and the Lancet believe EBM anymore? Not at all. So neither should we. We can’t believe evidence based medicine until the evidence has been cleaned up from the corrupting influence of commercial interests.

Financial conflicts of interest (COI), also known as gifts to doctors, is a well accepted practice. A national survey in the New England Journal of Medicine in 2007 https://www.nejm.org/doi/pdf/10.1056/NEJMsa064508 shows that 94% of physicians had ties to the pharmaceutical industry. This gravy train only rides in one direction. From Big Pharma to the wallets of doctors. Sure Big Pharma can simply pay doctors directly, and it does plenty of that. It’s no surprise that medical students with more exposure to pharmaceutical reps develop a more positive attitude towards them https://www.ncbi.nlm.nih.gov/pubmed/20672554. Many medical schools have limited exposure of medical students in response, but declined to get off the gravy train themselves. There is a simple relationship between how prominent a physician is (more articles published — almost always academic doctors and professors) and how much money they take from Big Pharma. Mo prominent = mo money. Further, there is a ‘clear and strong link’ between taking industry money and minimizing the risk of side effects of medications https://www.ncbi.nlm.nih.gov/pubmed/20299696.  What, you thought people teach at prestigious institutions like universities for the good of mankind? Maybe that’s why they went there, but that’s not why they stay. They came for the science. They stayed for the money.

KillingForProfitGraph3

So here’s a damning list of all the problems of EBM

  1. Selective Publication
  2. Rigged outcomes
  3. Advertorials
  4. Reprint Revenues
  5. Bribery of Journal Editors
  6. Publication Bias
  7. Financial Conflicts of Interests

When the evidence base of medicine is bought and paid for, people die. That is how doctors have created this opioid crisis that kills thousands of people. Pharmaceutical companies want to pay off doctors, just as drug lord want to pay off judges and police officers. Doctors, being human, should put safeguards against this temptation. Unfortunately, doctors and universities have been willing participants in this game of killing for profit https://www.facebook.com/NathanGillOfficial/videos/2134121280141545/.   We need to end it now. End the corruption of the universities. Stop the bribery of doctors.

Dr. Aseem Malhotra will be speaking about this very issue to the European Parliament this Thursday:  https://www.dietdoctor.com/live-stream-big-food-big-pharma-killing-profit

Nephrologist. Special interest in type 2 diabetes reversal and intermittent fasting. Founder of Intensive Dietary Management Program.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

“© [Article Date] GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here http://www.greenmedinfo.com/greenmed/newsletter.”

______________

**Comment**

I am so thankful people are speaking out about what’s happening to Science.  This is being seen across the board, but particularly with tick borne illness.  This complex illness has been riddled with fraud, collusion, and conflicts of interest from the get-go and hasn’t changed in over 40 years.

For more:  https://madisonarealymesupportgroup.com/2017/01/13/lyme-science-owned-by-good-ol-boys/

https://madisonarealymesupportgroup.com/2018/06/14/corruption-human-rights-violations-against-lyme-doctors-scientists-and-parents-now-on-united-nations-record/

https://madisonarealymesupportgroup.com/2017/08/19/dr-liegner-guidelines-used-by-managed-care-causing-lyme-deaths/

https://madisonarealymesupportgroup.com/2017/01/02/fake-science/

https://madisonarealymesupportgroup.com/2017/09/25/trump-should-eliminate-fake-science/

https://madisonarealymesupportgroup.com/2017/01/28/sit-down-science/

https://madisonarealymesupportgroup.com/2017/12/05/bought-documentary-on-pharma-vaccines-gmos/